Abstract
Background
Rubella is a leading vaccine-preventable cause of birth defects. We conducted this study to evaluate the rubella surveillance system in South Africa from 2016 to 2018. The rubella surveillance system had not been evaluated since its inception; therefore, a formal evaluation is necessary to assess key attributes and to ascertain the extent to which the system achieves its objectives.
Methods
We conducted a cross-sectional study to assess the usefulness, simplicity, positive predictive value, timeliness, and data quality of the rubella surveillance system from 2016 to 2018. We reviewed retrospective rubella surveillance data and conducted a survey with key stakeholders of the system. We compiled a summary report from the survey and calculated the annualized detection rate of rubella and non-rubella febrile rash, positive predictive value, the proportion of complete records, and timeliness between the surveillance steps. We compared our results with recommended performance indicators from the 2015 revised World Health Organization African regional guidelines for measles and rubella surveillance.
Results
The rubella surveillance system was useful but weak in terms of simplicity. The annualized detection rate of rubella febrile rash was 1.5 per 100,000 populations in 2016, 4.4 in 2017, and 2.1 in 2018. The positive predictive value was 29.1% in 2016, 40.9% in 2017, and 32.9% in 2018. The system did not meet the timeliness goal in the health facility component but met this goal in the laboratory component. The system had poor data quality, particularly in the health facility component.
Conclusions
The rubella surveillance system was useful, although it was not simple to use and had low PPV, poor timeliness, and poor data quality. Efforts should be made to improve the system’s simplicity, PPV, timeliness, and data quality at the facility level.
Publisher
Public Library of Science (PLoS)
Reference35 articles.
1. Centers for Disease Control and Prevention. Rubella (German Measles) 2019 [cited 2019 February 20]. https://www.cdc.gov/rubella/.
2. World Health Organization. Global measles and rubella strategic plan: 2012 2012 [cited 2018 September 15]. https://www.who.int/publications/i/item/9789241503396.
3. Rubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level;C Atreya;Birth Defects Research Part A: Clinical and Molecular Teratology,2004
4. Rubella virus replication and links to teratogenicity;J-Y Lee;Clinical microbiology reviews,2000
5. Rubella vaccines: WHO position paper–July 2020–Note de synthèse: position de l’OMS concernant les vaccins antirubéoleux;Mondiale de la Santé, World Health Organization;Weekly Epidemiological Record = Relevé épidémiologique hebdomadaire,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献